We investigated the role of connexin 43 (Cx43) in maintaining the integrity of mitochondria in brown adipose tissue (BAT). The functional effects of Cx43 were evaluated using inducible, adipocyte-specific Cx43 knockout in mice (Gja1 adipoq KO) and by overexpression and knockdown of Cx43 in cultured adipocytes. Mitochondrial morphology was evaluated by electron microscopy and mitochondrial function and autophagy were assessed by immunoblotting, immunohistochemistry, and qPCR. The metabolic effects of adipocyte-specific knockout of Cx43 were assessed during cold stress and following high fat diet feeding. Cx43 expression was higher in BAT compared to white adipose tissue. Treatment with the β3-adrenergic receptor agonist CL316,243 increased Cx43 expression and mitochondrial localization. Gja1 adipoq KO mice reduced mitochondrial density and increased the presence of damaged mitochondria in BAT. Moreover, metabolic activation with CL316,243 further reduced mitochondrial integrity and upregulated autophagy in the BAT of Gja1 adipoq KO mice. Inhibition of Cx43 in cultured adipocytes increased the generation of reactive oxygen species and induction of autophagy during β-adrenergic stimulation. Gja1 adipoq KO mice were cold intolerant, expended less energy in response to β3-adrenergic receptor activation, and were more insulin resistant after a high-fat diet challenge. Collectively, our data demonstrate that Cx43 is required for maintaining the mitochondrial integrity and metabolic activity of BAT.
Here, we demonstrated that Cx43 is targeted to mitochondria in adipocytes and that direct pharmacological activation of β3 adrenergic receptors, which appears to bypass the need for intercellular communication, strongly increases expression and mitochondrial targeting of Cx43. We then used adipocyte-specific knockout of Cx43 in adult mice to characterize metabolic phenotype caused by genetic deletion of Cx43. We also studied effects of in vitro knockdown of Cx43 in adipocytes to characterize cellular responses and mechanisms that lead to mitochondrial dysfunction upon Cx43 downregulation.
Results
Cx43 is the most abundant gap junctional protein in brown adipose tissue. Our previous global mRNA profiling of inguinal adipocytes identified a significant expression of several connexins, including Gja1, Gjc1, Gjd4, Gja4, and Gjb5 12 . To compare the expression levels of connexin subtypes in white adipose tissue (WAT) and BAT, we performed a quantitative polymerase chain reaction (qPCR) analysis of the connexins in interscapular BAT (iBAT), inguinal WAT (iWAT), and perigonadal WAT (gWAT) (Fig. 1A) . In general, Gja1 (encoding Cx43) was the most abundantly expressed connexin subtype in BAT and WAT (Fig. 1A) . BAT had the highest Gja1 expression, while gWAT had the lowest. Similarly, Cx43 protein was more abundant in BAT than in gWAT and iWAT. Five days of treatment with a selective β3-adrenergic receptor agonist, CL316,243 (CL), significantly increased Cx43 expression in iWAT, gWAT, and BAT (Fig. 1B) .
We also examined the time course of the induction of Cx43 and UCP1 proteins by CL treatment (Fig. 1C-E ). Five days of CL treatment upregulated Cx43 in BAT, iWAT and gWAT. Simultaneously, an upregulation of UCP1 expression was observed in iWAT, suggesting that Cx43 may be involved in mediating the metabolic activation and browning of WAT induced by β3-adrenergic stimulation. As expected, gWAT did not show a significant upregulation of UCP1 after 5 days of CL treatment, yet the upregulation of Cx43 was significant. The appearance of multiple bands on western blots suggested phosphorylation of Cx43 13 . Collectively, the activation of BAT and browning of WAT induced by β3-adrenergic stimulation were accompanied by increased Cx43 expression, suggesting a potential role of Cx43 in metabolic activation in brown/beige adipocytes.
β3-adrenergic stimulation increases the mitochondrial localization of Cx43 in adipocytes.
We examined the distribution of Cx43 expression in BAT by immunofluorescence histochemistry ( Fig. 2A and B ). As expected Cx43 was detected on brown adipocyte plasma membrane in the BAT of control mice and its expression was increased by treatment with CL for 3 days. After CL treatment, Cx43 was detected in cytosolic location (Fig. 2C ). Although distribution of Cx43 is heterogeneous, double label staining for Cx43 and mitochondrial enzyme, medium chain acyl dehydrogenase (MCAD), indicated that Cx43 was also closely associated with some of mitochondria after 3 days of CL treatment (Fig. 2C ). To further determine the subcellular localization of Cx43, we performed a western blot analysis of BAT homogenates that were fractionated by differential density centrifugation. CL-induced elevation of Cx43 was largely restricted to heavy membrane fractions containing mitochondria and plasma membrane (Figs 2D and S1). Normalization to a mitochondrial protein, COXIV, indicated significant increase in mitochondrial Cx43 in BAT of CL-treated mice compared to control conditions ( Fig. 2E ).
To enrich for proteins that are targeted to mitochondrial inner membrane, we incubated crude mitochondrial fractions with trypsin, and evaluated protein content of treated fractions following recovery by centrifugation. As shown in Fig. 2F , trypsin incubation depleted the outer mitochondrial membrane protein (i.e. Tom22) as well as plasma membrane markers (e.g. Na + /K + -ATPase, Caveolin1). In contrast, Cx43 within the mitochondrial/heavy membrane fraction from BAT of CL-treated mice was partially resistant to trypsin digestion, whereas that from controls was nearly completely removed. Collectively, data suggest that CL treatment increased mitochondrial targeting of Cx43 in brown adipose tissue.
Adipose-specific Gja1 knockout reduces mitochondrial density and increases the appearance of damaged mitochondria in BAT.
To determine the in vivo functions of Cx43 in adipose tissue, we inactivated Gja1 in adult mice using adiponectin/CreER-driven recombination. We selected this drug-inducible conditional knockout system to avoid possible chronic or developmental effects. Tamoxifen treatment of Adipoq-CreER/Gja1 flox/flox mice effectively deleted CX43 expression, but was without effect in tamoxifen injected mice lacking Cre. Inducible adipocyte-specific Gja1 adipoq KO mice (Gja1 adipoq KO) showed reduced UCP1 protein levels in BAT under basal conditions and after CL stimulation (Fig. 3A ). In addition, western blot analysis of mitochondrial proteins indicated a reduction in BAT mitochondrial respiratory chain proteins ( Fig. 3A and B ). As intended, knockout of Cx43 did not alter the levels of phosphorylation of HSL after 4 h of acute CL treatment, nor did knockout affect the apparent desensitization of adrenergic signalling during chronic treatment ( Fig. 3C) . In contrast to the reduced mitochondrial UCP1, knockout of Cx43 did not affect induction of UCP1 mRNA levels ( Fig. 3D) . Similarly, induction of brown adipocyte markers such as Elovl3 and Dio2 was not affected by the genetic deletion of Gja1 (Fig. 3D ). In addition, gene downstream of PKA activation (Nor1 and Plin2) did not show any difference in expression between Gja1 adipoq KO and WT mice ( Fig. 3D) . Thus, the changes in the abundance of mitochondrial proteins, but not their mRNA transcripts, suggested that Cx43 might be involved in maintenance of mitochondrial function or integrity in adipocytes.
Electron microscopy of BAT demonstrated reduced mitochondrial density and the appearance of abnormal mitochondria in Gja1 adipoq KO mice ( Fig. 4A,B ). Analysis of the size distribution of mitochondria under basal conditions (22 °C) and following CL stimulation demonstrated the appearance of a population of large mitochondria, some as large as 4μm, that were never observed in wild type ( Fig. 4A-D) . Frequency of swollen/enlarged mitochondria (i.e. >1.5μ) was greater in the BAT of Gja1 adipoq KO mice ( Fig. 4D : chi square = 157; p < 0.00001).
Because the impaired mitochondrial integrity can induce compensatory responses and cell death signals, we examined autophagy in Gja1 adipoq KO mice. An immunoblot analysis of the autophagy marker LC3b suggested that autophagy in BAT was increased in the Gja1 adipoq KO mice compared to that in WT controls after CL SCIentIfIC RepoRtS | 7: 7159 | DOI:10.1038/s41598-017-07658-y treatment ( Fig. 4E ). Additionally, a qPCR analysis indicated the upregulation of genes involved in autophagy (Atg9a, Atg12, Atg7, Atg4b, and Naga) in BAT after 4 h of CL treatment (Fig. 4F ).
In vitro downregulation of Cx43 reduces mitochondrial content and increases oxidative stress in adipocytes. Because mitochondrial damage was observed in Gja1 adipoq KO mice, we investigated the potential protective roles of Cx43 in mitochondrial homeostasis in adipocytes differentiated from C3H10T1/2 cells using siRNA knockdown of Cx43. Treatment of adipocytes with siRNA reduced Cx43 mRNA and protein by more than 50%, which were maintained for 4 days after siRNA transfection ( Fig. 5A and B ). Consistent with knockout in vivo, knockdown of Cx43 (Gja1) significantly reduced expression of components of complex II (SDHB), III (UQCRC2), and V (ATP5A), but not I (NDUFB8) ( Fig. 5A ). Immunostaining for LC3B puncta indicated a greater autophagic response to isoproterenol in Cx43 (Gja1)-knockdown adipocytes ( Fig. 5C ). Double label staining with LC3B and the mitochondrial dye, MitoTracker ® , indicated a close association between these two stains, suggesting an increase in mitophagy ( Fig. 5C ). Moreover, the suppression of Cx43 expression in adipocytes increased the expression of genes involved in autophagy (Atg7, Tfe, Ctsz, and Ctss) after isoproterenol treatment in cells treated with siRNA to knock down Gja1 (Fig. 5D ). Ratio of LC3BII to LC3BI was also increased by siRNA, and treatment with chloroquine (an inhibitor of lysosomal degradation) further increased accumulation of LC3BII compared to controls ( Fig. S2C ). Next, autophagic flux was measured using an LC3 tandemly tagged with fluorescent proteins that detect lysosomal degradation 14 in C3H10T1/2 cells. This system expresses a chimeric LC3 fused with eGFP and mCherry, thus pH sensitive decrease in GFP intensity over RFP intensity indicates autolysosome formation. As shown in Fig. 5E , Gja1 knockdown with siRNA increased autophagic flux, indicated by a decrease in the ratio between the intensities of green and red fluorescence under basal and isoproterenol-activated conditions (Fig. 5E ).
To further investigate the protective roles of Cx43 against mitochondrial oxidative stress, we monitored ROS generation and the membrane potential of mitochondria with Cx43 inhibition. β3-adrenergic stimulation with . Immunoblot analysis of Cx43 and UCP1 expression (A) and mitochondrial proteins involved in oxidative phosphorylation (B) in BAT of Gja1 adipoq KO mice and WT controls treated with CL up to 3 days. Twoway ANOVA revealed significant main effects of Gja1 expression in mitochondrial proteins (UCP1: p = 0.0001, ATP5A: p = 0.0004, UQCRC2: p = 0.015, NDUFB8: p = 0. 0004) and significant interaction of genotype and treatment (UCP1: p = 0.0166, NDUFB8: p = 0.0264). Significant differences between WT and KO were determined by post-hoc pairwise comparison with Bonferroni correction (mean ± SEM; n = 4 per condition, *p < 0.01, **p < 0.05, ***p < 0.001). (C) Immunoblot analysis of p-HSL and HSL expression in BAT of Gja1 adipoq KO mice and WT controls treated with CL up to 3 days (mean ± SEM; n = 4 per condition). (D) qPCR analysis of brown adipocyte markers and genes involved in downstream signaling of PKA activation in BAT of mice treated with CL for up to 5 days and untreated control mice. Two-way ANOVA revealed no significant main effects of Gja1 expression in mRNA levels (Ucp1: p = 0.4829, Ppargc1a: p = 0.178, Elovl3: p = 0.261, Dio2: p = 0.291, Nor1: p = 0.583, Plin2: p = 0.278, Lipe: p = 0.830) (mean ± SEM; n = 4 per condition). (Oil Vehicle controls in Fig. S2 , Immunoblots accompanied by size markers in Fig. S8 ).
isoproterenol treatment increased ROS levels over time ( Fig. 5F ). Gja1 knockdown using siRNA accelerated ROS generation after isoproterenol treatment, and this difference was sustained for 2 h after isoproterenol treatment.
The results indicate that Cx43 contributes to the maintenance of mitochondrial integrity and metabolic activity by reducing membrane potential and decreasing ROS generation.
To examine the effect of Cx43 expression in adipocytes, we overexpressed Gja1 in C3H10T1/2 cells and differentiated them into adipocytes. Endogenous Cx43 was detected in empty-vector control treatments of differentiated C3H10T1/2 cells, and Gja1 overexpression increased the abundance of Cx43 by 3-fold ( Fig. S1 ). Gja1 overexpression did not increase the abundance of mitochondrial proteins in adipocytes ( Fig. S1 ). Although Ppargc1a expression was induced in Gja1-overexpressing cells, the mRNA levels of other mitochondrial proteins (Cox8b and Mcad) did not change with Gja1 overexpression. In addition, the expression of brown adipocyte markers such as Elovl3 and Cidea was not affected by Gja1 overexpression (Fig. S2 ).
Adipose-specific Gja1 knockout produces defective metabolic phenotypes. Next, we investigated the metabolic phenotype of Gja1 adipoq KO mice by indirect calorimetry (Fig. 6A,B ). As expected based on the reduced mitochondrial activity of BAT in Gja1 adipoq KO mice, energy expenditure of Gja1 adipoq KO mice was (E) Immunoblot analysis of LC3I/LC3BII ratio in BAT of Gja1 adipoq KO mice and WT controls treated with CL up to 3 days. Two-way ANOVA revealed significant main effects of Gja1 expression on LC3BII/LC3BI ratio (p = 0.0053).(mean ± SEM; n = 3 per condition). (F) qPCR analysis of autophagy markers in BAT of mice treated with CL for up to 3 days. Two-way ANOVA revealed significant main effects of Gja1 expression in mRNA levels (Atg9a: p = 0.0001, Atg7: p = 0.0041, Atg4b: p = 0.017, Naga: p = 0.0001). (mean ± SEM; n = 3 per condition, *p < 0.01, **p < 0.05, ***p < 0.001). (Immunoblots accompanied by size markers in Fig. S9 ). Twoway ANOVA revealed significant main effects of Gja1 expression in mRNA levels (Atg9a: p = 0.0001, Atg7: p = 0.0041, Atg4b: p = 0.017, Naga: p = 0.0001). Significant differences between controls and siRNA knockdown were determined by post-hoc pairwise comparison with Bonferroni correction (mean ± SEM; n = 4 per condition). (E) Flow cytometric analysis of autophagic flux in adipocytes differentiated from C3H10T1/2 cells overexpress eGFP-mCherry-LC3, transfected with siRNA targeting Gja or scramble control. The adipocytes were treated with isoproterenol or vehicle for 2hr before analysis. GFP/RFP ratio represents autophagic flux (mean ± SEM; t-test, n = 3, ***p < 0.001). (F) ROS generation during the course of isoproterenol treatment for up to 2 hr measured by H2-DCF fluorescence. (Immunoblots accompanied by size markers in Fig. S10 ).
slightly reduced under basal conditions compared to WT mice. Whereas the immediate thermogenic response to injection of CL316,243 was similar in both genotypes, the sustained response over 12 hrs were significantly lower in Gja1 adipoq KO mice (Fig. 6A) . Interestingly, the respiratory exchange ratio was lower in Gja1 adipoq KO mice (Fig. 6B) , indicating a preference for free fatty acid over glucose, and their overall metabolic flexibility was defective in Gja1 adipoq KO mice. . Two-way ANOVA revealed significant main effects of genotype (GTT: p = 0.029, ITT: p = 0.047) and diet (GTT: p = 0.001, ITT: p = 0.0003) on area under the curve of GTT and ITT plots. Significant differences between WT and Gja1 adipoq KO were determined by post-hoc pairwise comparison with Bonferroni correction (mean ± SEM; *p < 0.05, NS = non-significant).
SCIentIfIC RepoRtS | 7: 7159 | DOI:10.1038/s41598-017-07658-y When challenged with acute cold stress, Gja1 adipoq KO mice exhibited greater reduction in core body temperature and lower surface temperature over the interscapular BAT ( Fig. 6C-E) . Gja1 adipoq KO mice gained body weight similarly to WT mice during 8 weeks of high fat diet feeding (Fig. 6F ). However, Gja1 adipoq KO mice after 8 weeks of high fat diet feeding manifested insulin resistance, as measured by glucose tolerance tests (Fig. 6G ).
Discussion
The current study confirms that Cx43 is strongly upregulated by direct β3-adrenergic receptor stimulation in adipose tissue 7 and further demonstrates that significant fraction of Cx43 is targeted to mitochondria in brown adipocytes where it plays an essential role in the maintenance of mitochondrial integrity. It is generally accepted that a major function of Cx43 is to form intercellular gap junction to mediate cell-to-cell communication by allowing the passage of ions and small molecules, such as cAMP 5, 15 . In this regard, recent work has suggested a critical role of Cx43 in coupling of cAMP between adipocytes during beiging of WAT in response to cold stress 7 . Although propagation of the sympathetic nerve signaling through gap junctions is required to facilitate remodelling of WAT with sparse innervation, it does not appear to be critical in BAT with relatively dense innervation 16 . However, the expression levels of Cx43 is much higher in BAT compared to WAT, thus we attempted to investigate a role of Cx43 in BAT metabolism apart from gap junctional communication.
To bypass impact of gap junctions in the propagation of sympathetic activation through cAMP coupling, we pharmacologically induced Cx43 upregulation via CL treatment, which can be uniformly effective in adipocytes that express β3-adrenergic receptors, instead of using neural activation. In this model, we confirmed that PKA downstream signalling was similarly activated in Gja1 adipoq KO and WT mice. We established that Cx43 was abundant in mitochondrial fraction as well as plasma membranes in adipose tissue, and demonstrated that the abundance of Cx43 on the plasma membrane was not significantly changed after CL treatment, yet its mitochondrial localization was nearly tripled in brown adipocytes. It is likely that nascent Cx43 is targeted to mitochondria during ADRB3 stimulation. In support, previous work has demonstrated that Cx43 can be sorted to the inner mitochondrial membrane through heat shock protein 90-mediated TOM pathways. 8 The genetic deletion of Cx43 compromised the maintenance of mitochondrial integrity and upregulated autophagy in BAT, suggesting that the translocation of Cx43 to mitochondria is a part of the protective mechanism of mitochondria against increased metabolic activity in response to β3-adrenergic stimulation.
We confirmed that β3-adrenergic stimulation increases ROS generation in cultured adipocytes and demonstrated that the inhibition of Cx43 further upregulated production of ROS and membrane potential 17 . It is presently unclear how mitochondrial Cx43 alters membrane potential and ROS generation. Previous work has reported that Cx43 can be translocated into the inner mitochondrial membrane through the heat shock protein 90-dependent translocase of the outer membrane pathway 8 . In general, several factors that increase ROS generation include a high proton gradient, high NADH/NAD + and CoQH 2 /CoQ ratios, and a low local O 2 concentration 17 . Thus, we speculate that Cx43 in the mitochondrial membrane could modulate ion fluxes or redox status, and thereby contribute to regulating the membrane potential. Whether mitochondrial Cx43 directly interacts with mitochondrial ion channel proteins to reduce membrane potential and supress ROS production is an important question for future studies. We showed that downregulation of Cx43 influenced expression levels of Atg9a, Atg7, Atg12 and Atg4b. Although the transcriptional control of Atg gene expression was not examined in this study, it would be informative to further investigate effects of Cx43 on the regulation of transcription factors related to autophagy induction.
While diverse roles of gap junctions have been reported 6, 15 , it has been shown that gap junctions play critical roles in adipogenesis 18 and lipid metabolism 4 of adipocytes. For instance, recent work demonstrated that an increase in calcium levels after treatment with capsaicin is mediated by Cx43 and promotes lipolysis in visceral adipose tissue 4 . It would be informative to study role of Cx43 in other subcellular location in adipocytes. In addition to Cx43 in mitochondria, we cannot exclude the possibility that Cx43 in other subcellular compartments may have roles in adipocyte function and mitochondrial homeostasis. In this regard, a recent study demonstrated that Cx43 exerts anti-autophagic effects by interacting with autophagy signalling mediators in the plasma membrane 19 .
Although the current study focused on Cx43 in BAT, the role of mitochondrial Cx43 in WAT deserves further investigation. We demonstrated that WAT showed increased Cx43 expression during β3-adrenergic remodelling. In addition, cultured white adipocytes that did not express UCP1 also showed increased ROS generation and autophagy after the inhibition of Cx43 expression. Thus, Cx43 might be a general protective mechanism against mitochondrial oxidative stress in adipocytes. We suggest that a lack of Cx43 in white adipocytes could increase their sensitivity to inflammation and cell-death induced by lipolysis. Our previous work suggested that β3-adrenergic stimulation increases the apoptotic death of adipocytes in gonadal adipose tissue 16, 20, 21 and it is possible that the upregulation of Cx43 in adipocytes and its targeting into mitochondria are required for resolving the transient inflammatory response induced by β3-adrenergic stimulation. It remains to be determined whether the overexpression of Cx43 in WAT might protect against oxidative stress and lipolysis-induced cell death during β3-adrenergic stimulation.
The activation of mitochondrial metabolism in BAT can increase energy expenditure to control energy homeostasis 2 . In general, a decrease in mitochondrial activity is involved in the pathogenesis of metabolic disorders and the aging process 22 . Furthermore, a failure to counteract the oxidative stress generated from mitochondrial respiration can initiate cell death processes and contribute to the development of metabolic disease 22 . Thus, understanding the adaptive responses of mitochondria to metabolic challenges and the coordinated upregulation of oxidant defence mechanisms to maintain mitochondrial quality is central to combating metabolic disease. The adaptation of mitochondria to catabolic stimuli, combined with the induction of protective mechanisms against SCIentIfIC RepoRtS | 7: 7159 | DOI:10.1038/s41598-017-07658-y oxidative stress, may represent a strategy that could be developed for therapeutic applications, and mitochondrial gap junctional proteins in adipocytes may be pharmaceutical targets for combating metabolic disease.
Methods

Animals.
All animal experiments were conducted in strict compliance with the guidelines for humane care and use of laboratory animals as specified by the Ministry of Food and Drug Safety. All animal protocols were approved by the Institutional Animal Care and Use Committees at Yonsei University. C57BL/6 mice (5-6 wk old, male) were purchased from Orient Bio (Gyeonggi-Do, South Korea). Gja1 flox/flox mice (stock #008039: B6.129S7-Gja1tm1Dlg/J) and Adipoq-CreER mice (Stock #024671: B6.129-Tg (Adipoq-cre/Esr1*)1Evdr/J) were purchased from the Jackson Laboratory and crossed to produce inducible adipose tissue specific Gja1 (the gene for Cx43) knockout (Adipoq-CreER/Gja1 flox/flox ) mice and Gja1 flox/flox mice without CreER for control wild type mice. Genotyping was performed as described previously 23, 24 . Mice were housed at 22 °C and maintained on a 12-h light/12-h dark cycle with free access to standard chow diet and water at all time. For Cre recombination, double transgenic mice (Adipoq-CreER/Gja1 flox/flox mice, 5 week old) and wild type controls (Gja1 flox/flox mice without CreER) were treated with tamoxifen dissolved in sunflower oil (Sigma, 75 mg/kg) by oral gavage on each of 5 consecutive days. Also, we included vehicle (oil)-treated control groups to confirm specific induction of Cre recombinase activity upon tamoxifen treatment in adipose tissue. Experiments were started 10 days after the last dose of tamoxifen. For β3 adrenergic receptor stimulation, mice were treated with CL316,243 (Sigma, St. Louis, MO) (1 mg/kg/day) by intraperitoneal injection for up to 5 days. For the high fat diet (HFD) experiments, 60% fat diet (D12492, Central Lab. Animal Inc.) was introduced at 7 weeks of age and continued for 8 weeks.
For exposure to cold stress, mice were single caged in cold room (4 °C) and body temperature was measured by thermometers (New Homeothermic Blanket Monitoring System, Harvard Apparatus, Canada) with rectal probe and images were taken with Infra-red camera (CX320, COX, South Korea).
For glucose tolerance test and insulin tolerance test, mice were given D-glucose (2 mg/ml, sigma) and insulin (0.75U/kg, Sigma) by intraperitoneal injection respectively, and glucose concentrations were measured at indicated time points.
Metabolic measurements were obtained using indirect calorimetry system (PhenoMaster, TSE system, Bad Homburg, Germany). The mice were acclimatized to the cages for 2 days, and O 2 consumption (VO 2 ), CO 2 production (VCO 2 ), food intake and locomotor activity were monitored for 3 days while food and water were provided ad libitum.
Cell Culture
For adipogenic differentiation, C3H10T1/2 mouse embryonic fibroblasts (American Type Culture Collection (ATCC), Manassas, VA) were cultured to confluence in growth medium (DMEM supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin at 37 °C in a humidified atmosphere with 5% CO 2 and then exposed to bone morphogenetic protein 4 (20 ng/ml; R&D Systems, Minneapolis, MN) followed by exposure to differentiation medium (DMEM supplemented with 10% FBS, 1% P/S, 2.5 mM isobutylmethylxanthine, 1 μM dexamethasone, and 1 μg/ml insulin for 3 days and then maintained in medium containing 1 μg/ml insulin for 4 d. To induce β-adrenergic stimulation, differentiated adipocytes were incubated in growth medium for 24 hours, and treated with isoproterenol (10μM, Sigma). For inhibition of autophagy, choloroquine (an inhibitor of late phase (lysosomal degradation), 50μM, Sigma) and 3-methyl adenine (3-MA, an inhibitor of early phase, 10 mM, Sigma) were used. Adipocytes were treated with inhibitors for 30 min before isoproterenol treatment.
For Gja1 knockdown, siRNA targeting Gja1 (Sigma, CAT. #EMU006781) were transfected into adipocytes differentiated from C3H10T1/2, using lipofectamine (ThermoFisher).
To prepare Cx43 overexpressing preadipocytes, C3H10T1/2 cells were infected with pLPCX-CX43-IRES-GFP (Addgene, plasmid #65433, a gift from Trond Aasen) 25 by using retrovirus infection described previously. Briefly, for retroviral infections, viral constructs were transfected into phoenix cells using lipofectamin2000 (ThermoFisher). Supernatants were collected, supplemented with 8 mg/ml hexadimethrine bromide (Sigma) and then exposed to the cultures. Infected preadipocytes were selected with 2 μg/ml of puromycin for 1 week.
Alternatively, differenitated adipocytes from C3H10T1/2 cells were infected wth pLVX-EIP-hCx43 by using lentivirus infection. Briefly, human Cx43 cDNA was amplified with PCR using 5′-GC TCT AGA ACC ATG GGT GAC TGG AGC GC-3′ and 5′-GC TCT AGA CTA GAT CTC CAG GTC ATC AGG C-3′ and inserted at XbaI site of pLVX-EF1a-IRES-Puro (Clontech), generating pLVX-EIP-hCx43. To produce lentivirus expressing hCx43, pLVX-EIP-hCx43, psPAX2 (Addgene, plasmid #12260), and, pMD2.G (Addgene, plasmid #12259) were mixed at 4:3:1 and transfected into HEK293T cells with iN-fect (iNtRON Biotechnology, Seongnam, Korea) overnight. The conditioned medium was harvested after 48 hours and cleared with filtration through 0.44 nm pore before use.
For autophagic flux analysis, C3H10T1/2 cells were infected with pBABE-puro mCherry-EGFP-LC3B 14 (Addgene, plasmid #22418, a gift from Jayanta Debnath) by using retrovirus infection as described above. For autophagic flux analysis, adipocytes differentiated from C3H10T1/2 cells that express mCherry-EGFP-LC3B was analyzed by using BD FACSAria III (BD Biosciences, San Jose, CA, USA). Raw data were processed using FlowJo software (Tree Star, Ashland, OR, USA).
To measure ROS production, adipocytes differentiated from C3H10T1/2 cells were treated with 10μM isoproterenol for indicated time and then exposed to 20μM H2DCFDA (Thermo Fisher Scientific) for 30 min. 40 nM H 2 O 2 (Sigma) was used as a positive control. Fluorescence intensity was determined by Tecan microplate reader with 485 nm excitation and 535 nm emission. Alternatively, cellls were treated with CellROX Green Reagent (Thermo Fisher) for 30 min for ROS detection by fluorescence microscopy. Subcellular fractionation. Subcellular fractionation was performed as described previously 26, 27 . Briefly, from tissue homogenates in fractionation buffer (containing 3 mM HEPES (pH7.4), 210 mM mannitol, 70 mM sucrose and 0.2 mM EDTA), cells and debris pellets were removed after centrifugation at 500 × g for 10 min. After centrifugation of the supernatant at 10,000 × g for 10 min, pellets containing mitochondria were collected and supernatant containing non-mitochondrial fraction wase centrifuged at 95000 × g for 2 h at 4 °C to obtain the plasma membrane fraction (pellet) and cytosolic fraction (supernatants). For the further purification, mitochondrial fractions were separated by differential centrifugation in sucrose gradient (30-60% w/v) at 100,000 × g. For outer mitochondrial membrane protein extraction, crude mitochondrial fractions were treated at 4 °C for 10 min or 30 min with PBS containing 0.05% trypsin (Sigma). Resulting fractions were subjected to western blot analysis.
Western blot. Protein extracts were prepared as previously described 29 . Western blot analysis was performed using primary antibodies against UCP1 (mouse, Abcam; or rabbit Alpha Diagnostic International), Cx43 (rabbit, Sigma), COX IV (rabbit, Cell Signaling), Na + /K + ATPase (rabbit, Cell Signaling), GAPDH (mouse, Bethyl), Total OXPHOS Rodent WB Antibody Cocktail (mouse, Abcam), p-HSL (rabbit, Cell signaling), HSL (rabbit, Cell Signaling), LC3b (rabbit, Cell signaling), caveolin1 (rabbit, Sigma), cabeolin 3 (rabbit, Sigma), Tom22 (Cell Signaling, rabbit) and a/b tubulin (rabbit, Cell Signaling) and secondary anti-mouse, and anti-rabbit horseradish peroxidase antibodies (Cell Signaling Technology, Danvers, MA), as described previously 28 . The blots were visualized with SuperSignal West Dura Substrate (Pierce-Invitrogen).
qPCR. For quantitative PCR analysis, RNA was extracted using TRIzol reagent (Invitrogen) and converted into cDNA by using high-capacity cDNA synthesis kit (Applied Biosystems, Waltham, MA). Quantitative PCR was performed using SYBR Green Supermix (Bio-Rad) and CFX Real-time PCR System (Bio-Rad) for 45 cycles, and the fold change for all the samples was calculated by the comparative cycle-threshold (Ct) method (i.e., 2− Δ Δ Ct method). Peptidylprolyl isomerase A was used as the housekeeping gene for mRNA expression analysis. cDNA was amplified using the primers listed in Table S1 or described previously 29 . Immunohistochemistry. Adipose tissue was processed for histological sections, and 5 μm-thick paraffin sections were subjected to immunohistochemical analysis, as previously described 30 .
Transmission electron microscopy (TEM). Small pieces of minced BAT (1~2mm 3 ) were BAT were immersed with 2% paraformaldehyde and 2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4). The tissue was removed and stored in the same fresh fixative overnight at 4 °C. Tissues were washed, post-fixed in 1% osmium tetroxide for 2 h, and dehydrated through an ascending series of ethanol, propylene oxide, and embedded in Epon mixture (Oken Shoji, Japan). Thin sections (70 nm) were made using Leica EM UC7 ultramicrotome (Leica Microsystems, Wetzlar, Germany), mounted on 200 mesh copper grids, stained with 2% uranyl acetate and 1% lead citrate for 5 min each, and observed under a Hitachi H-7650 transmission electron microscope (Hitachi, Tokyo, Japan) at the accelerating voltage of 80 kV.
Statistical analysis.
Statistical analyses were performed using GraphPad Prism 5 software (GraphPad Software, La Jolla, CA, USA.). Data are presented as mean ± SEM. Statistical significance between two groups was determined by unpaired t-test or Mann-Whitney test, as appropriate. Comparison among multiple groups was performed using a one-way analysis of variance (ANOVA) or two-way ANOVA, with Bonferroni post hoc tests to determine p values.
